These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 30576397

  • 1. A potent Lassa virus antiviral targets an arenavirus virulence determinant.
    Madu IG, Files M, Gharaibeh DN, Moore AL, Jung KH, Gowen BB, Dai D, Jones KF, Tyavanagimatt SR, Burgeson JR, Korth MJ, Bedard KM, Iadonato SP, Amberg SM.
    PLoS Pathog; 2018 Dec; 14(12):e1007439. PubMed ID: 30576397
    [Abstract] [Full Text] [Related]

  • 2. Epistastic Interactions within the Junín Virus Envelope Glycoprotein Complex Provide an Evolutionary Barrier to Reversion in the Live-Attenuated Candid#1 Vaccine.
    York J, Nunberg JH.
    J Virol; 2018 Jan 01; 92(1):. PubMed ID: 29070682
    [Abstract] [Full Text] [Related]

  • 3. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G, Trofimenko E, Mayor J, Fedeli C, Moreno H, Michel S, Heulot M, Chevalier N, Zimmer G, Shrestha N, Plattet P, Engler O, Rothenberger S, Widmann C, Kunz S.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30626681
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).
    Shao J, Huang Q, Liu X, Di D, Dileepan M, Brisse M, Ly H, Liang Y.
    J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462569
    [Abstract] [Full Text] [Related]

  • 6. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.
    Zhang X, Tang K, Guo Y.
    Antiviral Res; 2020 Feb 15; 174():104701. PubMed ID: 31877348
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE, Fénéant L, Szymańska-de Wijs KM, Kessler NP, Nelson EA, Shoemaker CJ, Schmaljohn CS, Polyak SJ, White JM.
    J Virol; 2019 Apr 15; 93(8):. PubMed ID: 30700611
    [Abstract] [Full Text] [Related]

  • 11. Restoration of virulence in the attenuated Candid#1 vaccine virus requires reversion at both positions 168 and 427 in the envelope glycoprotein GPC.
    Nunberg JH, Westover JB, York J, Jung KH, Bailey KW, Boardman KM, Li M, Furnell RS, Wasson SR, Murray JS, Kaundal R, Thomas AJ, Gowen BB.
    J Virol; 2024 Apr 16; 98(4):e0011224. PubMed ID: 38506509
    [Abstract] [Full Text] [Related]

  • 12. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
    Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C, Yekwa E, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Ferron F, Baize S.
    J Virol; 2018 Jun 15; 92(12):. PubMed ID: 29593043
    [Abstract] [Full Text] [Related]

  • 13. Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.
    Zhang Z, Takenaga T, Fehling SK, Igarashi M, Hirokawa T, Muramoto Y, Yamauchi K, Onishi C, Nakano M, Urata S, Groseth A, Strecker T, Noda T.
    J Virol; 2024 Jul 23; 98(7):e0071424. PubMed ID: 38809021
    [Abstract] [Full Text] [Related]

  • 14. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
    Wang P, Liu Y, Zhang G, Wang S, Guo J, Cao J, Jia X, Zhang L, Xiao G, Wang W.
    J Virol; 2018 Aug 15; 92(16):. PubMed ID: 29899092
    [Abstract] [Full Text] [Related]

  • 15. The Glycoprotein of the Live-Attenuated Junin Virus Vaccine Strain Induces Endoplasmic Reticulum Stress and Forms Aggregates prior to Degradation in the Lysosome.
    Manning JT, Yun NE, Seregin AV, Koma T, Sattler RA, Ezeomah C, Huang C, de la Torre JC, Paessler S.
    J Virol; 2020 Mar 31; 94(8):. PubMed ID: 31996435
    [Abstract] [Full Text] [Related]

  • 16. Lassa antiviral LHF-535 protects guinea pigs from lethal challenge.
    Cashman KA, Wilkinson ER, Posakony J, Madu IG, Tarcha EJ, Lustig KH, Korth MJ, Bedard KM, Amberg SM.
    Sci Rep; 2022 Nov 19; 12(1):19911. PubMed ID: 36402782
    [Abstract] [Full Text] [Related]

  • 17. Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junín Virus Infection in Guinea Pigs.
    Gowen BB, Hickerson BT, York J, Westover JB, Sefing EJ, Bailey KW, Wandersee L, Nunberg JH.
    J Virol; 2021 Jun 24; 95(14):e0039721. PubMed ID: 33952638
    [Abstract] [Full Text] [Related]

  • 18. Identification of a clinical compound losmapimod that blocks Lassa virus entry.
    Zhang X, Yan F, Tang K, Chen Q, Guo J, Zhu W, He S, Banadyga L, Qiu X, Guo Y.
    Antiviral Res; 2019 Jul 24; 167():68-77. PubMed ID: 30953674
    [Abstract] [Full Text] [Related]

  • 19. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
    Takenaga T, Zhang Z, Muramoto Y, Fehling SK, Hirabayashi A, Takamatsu Y, Kajikawa J, Miyamoto S, Nakano M, Urata S, Groseth A, Strecker T, Noda T.
    Viruses; 2021 Sep 03; 13(9):. PubMed ID: 34578344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.